Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

March 20, 2024 CE Webinar


The Premier March 20, 2024 CE webinar will be held from 12 - 1 pm EST. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.

WHAT LIES AHEAD - A LOOK AT THE BIOSIMILAR, INFECTIOUS DISEASES AND SPECIALTY/ONCOLOGY DRUG PIPELINE IN 2024-25

SPEAKER: Liya Davydov, PharmD, BCPS, BCGP, Senior Director, Clinical Pharmacy Services, Continuum of Care, Premier, Inc.

ACPE Universal Activity Number 0122-0000-24-008-L01-P/T [0.1 CEU] [1 Contact Hr.] (Live CE)

Date: Mar 20, 2024 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Mar 20, 2024 12:10 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Requirements for CE Credit

CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.

Support/Credits

Premier, Inc. has received no outside support for the administration of this program.

 

 

Registration closes on Mar 20, 2024 at 12:10 PM

Registration Closed  

Objectives

  • Identify biosimilar agents that have been recently approved, rejected or currently under regulatory review
  • List various reimbursement models/strategies for biosimilars
  • Identify notable agents that have been recently approved, rejected, in late stages of development or under regulatory review for infectious diseases indications
  • Identify specialty drugs currently under regulatory review for select indications
  • List oral and parenteral oncology agents currently under regulatory review for various cancers

Speaker(s)/Author(s)

Liya Davydov, PharmD, BCPS, BCGP
Senior Director, Clinical Pharmacy Services, Continuum of Care, Premier, Inc.

Activity Number

0122-0000-24-008-L01-P/T
Date: 03/20/24
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
Registration Closed